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Background: In this methodology article a thermal threshold testing device designed to test nociception in cats
was assessed in six dogs. The purpose of this study was to investigate baseline reproducibility of thermal thresholds
obtained by the contact heat testing device, to assess the influence of acepromazine and levomethadone and
fenpipramide in dogs. The relationship between change in nociceptive thermal threshold and the opioid0s plasma
concentration was determined. Six adult beagle dogs received levomethadone (0.2 mg/kg), acepromazine
(0.02 mg/kg) or saline placebo by intramuscular injection (IM) in a randomized cross-over design. Three baseline
nociceptive thermal threshold readings were taken at 15 minutes intervals prior to treatment. Further readings were
made at 15, 30, 45, 60, 90, 120, 150, 180, 210, 240, 270, 300, 330, 360, 420 and 480 minutes after injection. A
sedation score was assigned at every reading. Four saline placebo treatments were performed to assess baseline
reproducibility. Levomethadone serum concentrations were measured prior and 0.5, 1, 2, 4, 8, 12 and 24 hours after
drug dosing in a separate occasion.
Results: Acepromazine did not seem to increase the thermal threshold at any time. After levomethadone there
was a significant rise of the thermal threshold between 15 to 120 minutes at serum concentrations between
22.6-46.3 ng/mL. Baseline reproducibility was stable in adult beagle dogs.
Conclusion: The thermal threshold testing system is a suitable device for nociceptive threshold testing in dogs.
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Prior to clinical use of analgesic drugs in animals, object-
ive analgesiometric studies are necessary to assess the ef-
ficacy of the analgesic drugs. The purpose of this study
was to adapt a nociceptive thermal threshold testing de-
vice developed for the use in cats [1] to dogs, to evaluate
baseline reproducibility of thermal thresholds in adult
beagle dogs and to investigate the influence of sedation
and opioid administration. The relationship between
thermal nociceptive thresholds and plasma con-
centrations of levomethadone were determined. Our* Correspondence: Sabine.Kramer@tiho-hannover.de
1Department of Small Animal Medicine and Surgery (Hoffmann, Kästner and
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reproduction in any medium, provided the orhypothesis was that the μ-agonist levomethadone will in-
duce an increase in superficial thermal thresholds.
Methods
Dogs
Six healthy purpose-bred beagle dogs (2 spayed females,
4 castrated males) aged 6–8 years, with a mean weight
of 17.8 kg (± 2.0) were studied. They were housed in
groups and fed a commercial moist whole diet (Hills Ca-
nine P/D Prescription Diet™) twice a day. The dogs were
habituated to wearing the nociceptive thermal threshold
(TT) testing devices and to the area where the testing
was performed. The study was approved by ethical re-
view (licensed by the Lower Saxony State Office for
Consumer Protection and Food Safety, 33.9-42502-04-
07/1417) according to regulations of the German Animal
Welfare Act.ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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The thermode based nociceptive thermal threshold test-
ing device for ramped heating used in this study has
previously been described [1]. The equipment was devel-
oped for the use in cats and adapted for the use in dogs.
The thermal probe remained unchanged and only the
dimensions of the elastic bands used to attach the probe
to the thorax of the dogs were modified. Briefly, a ther-
mal probe acting as a temperature sensor and heater
element was attached to the dogs0 clipped thoracic wall
by an elastic band in the centre of an inflatable bladder
to provide constant contact between the probe and the
skin. The skin temperature was recorded and the probe
was heated at a constant rate of 0.6°C per second until
the dog reacted to the thermal stimulus or the safety
cut-out of 55°C was reached. All assessments were made
by the same observer who was blinded to treatment. A
skin flinch and/or a head turn towards the probe, was
considered a positive reaction. At this point the heating
was stopped immediately and the threshold temperature
recorded. All dogs tolerated the equipment well and the
cable between the thermal probe and the control unit
could remain attached to the thermal probe throughout
a testing day. This reduced direct manipulation of the
animals to a minimum.
Instrumentation
The evening before a testing day a 12 × 10 cm square on
the dogs’ lateral thorax was clipped. On a testing day
two dogs were placed in an area with a blanket, toys and
drinking water ad libitum. The thermal probe was
attached to the pressure bladder and secured against the
dog`s clipped thorax with an elastic band and allowed at
least 30 minutes to reach skin temperature. The pressure
was measured regularly to ensure constant contact over
time.
Study design
Three saline placebo treatment periods at least six weeks
apart were performed prior to drug studies. Additionally
levomethadone, acepromazine and saline placebo were
assessed in a randomized cross over study.
Three baseline readings were taken at 15 minutes
intervals prior to administration of levomethadone, ace-
promazine or saline placebo. Levomethadone is licensed
for dogs in Germany as a mixed preparation in combin-
ation with the parasympatholytic compound fenpipra-
mide, to offset opioid induced vagal tone (L-Polamivet,
Hoechst AG, Frankfurt, Germany). L-Polamivet contains
2.5 mg/mL levomethadon combined with 0.125 mg/mL
fenpipramide. The dogs were treated with levo-
methadone 0.2 mg/kg (combined with 0.01 mg/kg fen-
pipramide), acepromazine 0.02 mg/kg or 1 ml saline
placebo intramuscularly (IM) into the semimembranous/semitendinous muscle group using a 20 G needle
(Terumo Europe NV, Leuven, Belgium). Further readings
were made at 15, 30, 45, 60, 90, 120, 150, 180, 210, 240,
270, 300, 330, 360, 420 and 480 minutes after injection.
There was a washout of at least one week between treat-
ments and the thorax side was changed after every treat-
ment in a randomized cross over design.
Prior to the experiments, and 6 times during the study,
the probes were calibrated against a thermometer and
the results were adjusted on the basis of the derived
regression.
Reproducibility
Four saline placebo treatments were performed over a
six month period to assess baseline reproducibility for
the thermal testing system. The results were compared
between the six dogs and the four different placebo
groups.
Sham testing
All six untreated dogs were each tested five times with
the equipment randomly switched off and assessed by a
blinded observer. Each test was terminated after 45 sec-
onds if no response had occurred.
Influence of sedation
The degree of sedation was assessed using a numeric de-
scriptive scale (NDS). The NDS consisted of a scale ran-
ging from 0 to 3, with 0: no sedation; 1: mild sedation
(less alert but still active); 2: moderate sedation (drowsy,
recumbent but can walk); and 3: intense sedation (very
drowsy, unable to walk) [2].
Sedation score was assigned at every reading and the
area under the sedation score (AUC) was calculated and
compared between treatment groups. Acepromazine was
administered to evaluate the influence of sedation.
Blood sampling
The same 6 dogs were used for the pharmacokinetic
study but TT and blood collection was performed on
a separate occasion to minimize manipulation during
the thermal testing and to avoid stress induced
changes in the testing results. Samples were with-
drawn from the cephalic vein using a 20 G needle
(Terumo Europe NV, Leuven, Belgium) before and
0.5, 1, 2, 4, 8, 12 and 24 hours after drug dosing. The
blood was sampled in lithium heparin tubes and cen-
trifuged (12000 rpm) for 2 minutes. Serum was sepa-
rated and stored at - 18°C for one week before
levomethadone assays were performed.
Drug analysis
Levomethadone concentrations were measured after
serum samples were precipitated with zinc sulphate and
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HPLC-Triplequad-MS (LIPIDOMIX GmbH, Berlin,
Germany). Measurements were performed in multiple
reaction monitoring (MRM) mode. Two MRM transi-
tions were used for compound identification.
Methadone-D9 and EDDP-D3 were used as internal
standards and calibration was performed with 8 dif-
ferent concentrations in dilution series of 1:2. Calcu-
lation of the calibration was performed using Agilent
MassHunter Software (Agilent Technologies GmbH,
Böblingen, Germany). The limit of quantification
(LOQ) was 0.001 ng/ml. Calibration curve data was
constructed in the range of expected concentrations
of 25.0-0.20 ng/mL methadone. The regression correl-
ation coefficient (r) of the standard curve was
0.99999.Pharmacokinetic analysis
The pharmacokinetic analysis was performed using Win-
Nonlin 3.2 (Pharsight Corporation, Mountain View,
California, USA). The goodness of fit for the one-
compartment model used was evaluated based on the R2
and the values of the Akaike and Schwartz criteria.
Area under the concentration-time curve (AUC) was
calculated as well as the elimination half life (t1/2). The
peak concentration (Cmax) and time to peak concentra-
tion (Tmax) were determined according to standard
formula.Statistical analysis
Statistical analysis was carried out using SigmaStatW ver-
sion 3.5 and SAS Version 9.0. The graphic presentation
was done using GraphPadPrismW version 5.0.
Mean ± SD are reported unless otherwise stated. The
data were checked for normality using the Shapiro-Wilk
test. Variables not normally distributed were analyzed by
a Friedman test and a Wilcoxon signed-rank test.
The three baseline readings were averaged to give a
mean ± SD baseline value. Taking this value as time 0,
repeated-measures ANOVA followed by Dunnett0s test
was used to assess changes with time in response to
treatment. The area under the threshold curve (AUC)
was calculated for the time of significant threshold rise
for each drug and compared to each other as well as to
saline placebo using a Wilcoxon-signed-rank test (sum
of AUC). The area under the sedation curve (AUC) was
calculated for the time of significant degree of sedation
and compared among treatment groups using a
Wilcoxon-matched pairs test (sum of AUC). Multi-
Factor Analysis Variance was used to compare the inter-
action of the six dogs in relation to measuring time
point and saline placebo period to assess reproducibility.
P < 0.05 was considered significant.Results
The mean nociceptive thermal threshold of all six dogs
and 4 saline placebo treatments and for all time points
was 39.7°C ± 0.4°C. There was no significant difference
between the four saline placebo groups over the six
months period (Figure 1). Sham testing gave no false
positives and no false negatives. Following the intramus-
cular dose of 0.2 mg/kg levomethadone the mean max-
imum serum concentration of 46.3 ± 14.03 ng/mL was
reached after 1.25 hours. The area under the curve
(AUC) was 185.4 hr*ng/mL. Serum concentration
decreased with a half life of 2 hours.
After injection of 0.2 mg/kg levomethadone IM, there
was a significant rise of the nociceptive thermal thresh-
old between 15 to 120 minutes compared to baseline, sa-
line placebo and acepromazine. The maximum threshold
was 46.0°C ± 2.2°C 45 minutes after injection. The serum
concentration during a significant threshold rise was
22.6-46.3 ng/mL (Figure 2).
Acepromazine did not significantly increase the noci-
ceptive thermal threshold at any time (40.4°C ± 1.2°C).
The dogs had a sedation score between 1 and 3, 15 to
180 minutes after treatment with a significant increase
of sedation between 45 to 120 minutes (1.75 ± 0.5) com-
pared to baseline (0).
Levomethadone led to a sedation score between 1 and
3 from 30 to 270 minutes after treatment, with a signifi-
cant increase compared to baseline from 30–210 minutes
(1.98 ± 0.49). There was no significant difference be-
tween the degree of sedation after administration of
acepromazine compared to levomethadone (p = 0.06).
Degree of sedation induced by IM acepromazine or levo-
methadone was significantly different to saline-placebo
(p < 0.001).Discussion
It is well recognised that nociceptive threshold testing
does not provide the same stimulus as clinical pain, but
it can be used to assess the efficacy of analgesics with
cutaneous antinociceptive activity in the preclinical
phase for elaboration of adequate doses and dosing
intervals.
In the last few decades many different techniques have
been developed to perform thermal threshold testing in
dogs. Both fixed stimulus, where latency to response is
measured, and a threshold stimulus that elicits an effect
have been used as end points in analgesiometry. In 1941
Andrews and Workman [3] used a “Hardy-Wolff” appar-
atus [4] for thermal threshold testing in dogs. They
blackened the dogs` thoracolumbar area of the skin and
stimulated with radiant heat. In another study, a filament
lamp was attached to the hindlimb of dogs for thermal
threshold testing [5]. In a recent study, latency response
Figure 1 Mean ± SD thermal threshold (colored lines) and skin temperature (black lines) in °C after 4 saline treatments (gray vertical
line) over a six months period in 6 dogs.
Figure 2 Thermal threshold in relation to plasma concentrations. The green graph (circles) shows the thermal threshold (°C) after
administration of 0.2 mg/kg levomethadone intramuscularly. The red graph (triangles) illustrates the thermal threshold (°C) of the 4 saline
treatments. The blue graph (squares) demonstrates the plasma levomethadone concentration (ng/mL). Note the time points of significant
threshold rise (stars). All data are displayed as Mean ± SD of the 6 dogs.
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stant temperature of 60°C with a thermal probe [6].
In the present study, nociceptive thermal threshold
was measured by adapting equipment well established
for use in cats [7-12]. The testing device has previously
been used for nociceptive thermal threshold measure-
ments in horses [13,14], encouraging the adaption to an-
other species.
The equipment was well tolerated by the beagles who
wore the band for up to 10 hours without attempting to
remove or play with it. In contrast to the first study of
this device in cats [1] none of the dogs chewed the cable
between the probe and the control unit. Thus there was
no necessity to unplug the cable between tests which
reduced direct manipulation on the dogs. The flexibility
of the ribbon cable minimized the restriction on the
dogs, keeping a possible influence of restraint induced
stress low.
It is important to evaluate and adapt nociceptive
threshold testing methods for each species due to spe-
cies and individual variability. It is known that variations
in skin thickness and blood flow [15], hair covering and
epidermal pigmentation [16] as well as nociceptor distri-
bution may influence the thermal threshold.
Previous studies in cats investigated reproducibility by
6–12 repeated tests at 5-15- minute intervals in eight
untreated cats and further tests at 24 hours and repeated
this on only two occasions 3–6 months later. Reproduci-
bility was improved in cats during development of the
equipment and testing procedure by careful attention to
detail such as clipping, band placement and precise blad-
der pressure [1] and this accuracy was considered in the
present study.
In the first study of this device in cats, a safety cut-out
at 60°C led to minor skin lesions [1]. The safety cut-out
was adapted to 55°C to prevent thermal burns in the
present study.
Since there are many factors possibly influencing the
nociceptive thermal threshold, baseline reproducibility is
required prior to any testing of analgesic agents. In the
present study, three of the four saline placebo treat-
ments were assigned prior to drug testing. There was at
least six weeks between saline placebo treatment periods
to provide reproducible data over several months.
The effect of learning leading to recognition and sub-
sequent avoidance of the stimulus can be another factor
influencing the test results [17]. Sham testing showed
that the dogs did not anticipate the experiment. The
testing device used in this study, had the great advantage
that direct manipulation of the dogs could be reduced
to a minimum and no learned avoidance of the testing
device occurred. In addition it is presumed that en-
vironmental factors influence the response to painful
stimuli in animals [18,19]. Therefore the dogs werehabituated to wearing the testing device, the room in
which the testing was performed and the person per-
forming the tests.
Comparable to the studies in cats and horses using the
same testing device as in the current paper [1,8,13] ther-
mal threshold did not change significantly after placebo
saline injection in the present study.
Measurement of the plasma concentration of levo-
methadone gave us the opportunity to elucidate the rela-
tionship between blood concentration and effect
(Figure 2); however, it is important to take into consider-
ation that the analgesic effect correlates with the drug
concentration at the site of action- effect site (opioid
receptors in the central nervous system) and not neces-
sarily directly with the plasma concentration. Addition-
ally, the sampling schedule may not allow very accurate
estimates of pharmacokinetic parameters. Nevertheless,
a close relationship between serum concentration and
nociceptive thermal threshold was demonstrated for
levomethadone in this study (Figure 2).
To our knowledge there is little information about the
correlation between levomethadone plasma concentra-
tion and an analgesic effect in dogs. In this study, serum
concentrations of 22.6 to 46.3 ng/mL provided analgesia
in dogs. These concentrations were observed during sig-
nificant elevation of TT and not at steady-state, and the
relationship between concentration and effect is unlikely
to be direct. It is therefore likely that the changes in ef-
fect lagged behind the changes in concentration, and the
actual analgesic concentrations may be therefore have
been somewhat different. The duration of effect was 15
to 120 minutes after IM injection, with a maximum
threshold 45 minutes after injection.
Time to maximal plasma concentration in the present
study was reached after 1.25 hours, with a maximal
plasma concentration of 46.3 ± 14.0 ng/ml. In a recent
study, time to maximal plasma concentration was
reached after 1.26 hour, with maximal plasma concentra-
tions of 23.9 ± 14.4 ng/ml after subcutanoues adminis-
tration of 0.4 mg/kg methadone hydrochloride in dogs
[20]. Racemic methadone and levomethadone boths pro-
vide a comparable analgesic effect. Another study com-
pared analgesia following administration of either
0.3 mg/kg levomethadone or 0.6 mg/kg racemic metha-
done intramusculary (IM) to cats undergoing ovariohys-
terectomy. Post operative pain was scored at a number
of time points for up to four hours after surgery using a
scoring system comprised of physical and behavioural
measures, including wound palpation. The authors con-
cluded that both levomethadone and racemic metha-
done, at the doses tested, provided adequate analgesia
after ovariohysterectomy [21].
Opioids commonly produce sedation [22] due to their
interaction with μ and κ receptors [23]. Acepromazine
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testing results. It is the most widely used phenothiazine
sedative in veterinary medicine, and is considered not to
have a significant analgesic effect [5], although there is
controversy if phenothiazines produce analgesia [24-26].
In a recent study on cats, acepromazine alone and in
combination with tramadol increased the pressure
threshold whereas tramadol alone did not [26]. In con-
trast, no increase in thermal threshold occurred after ad-
ministration of acepromazine in horses, suggesting that
acepromazine does not have somatic antinociceptive
effects in the horse [14].
In the present study, degree of sedation was compared
between treatment groups. Acepromazine produced sed-
ation comparable to levomethadone at the dosage used,
but did not increase the nociceptive thermal threshold,
indicating that the testing system seems to measure only
the analgesic effect and is not influenced by sedation.
However, the study design and the small number of dogs
tested do not seem appropriate to demonstrate the lack
of an effect. Therefore, we cannot confirm with accept-
able certainty that saline placebo and acepromazine do
not have an effect on nociceptive thermal threshold,
even though the data itself shows relatively convincingly
that the thermal threshold likely does not change follow-
ing saline placebo or acepromazine administration.
Conclusion
The testing device is suitable to assess nociceptive ther-
mal thresholds in dogs and the analgesic response to an
opioid. Saline placebo thermal thresholds were stable
over a six month period and testing results appeared not
to be influenced by sedation alone.
Furthermore the methodology seems well suited for
investigation the thermal antinociceptive profile of
opioids in dogs with respect to onset and duration of ef-
fect, and concurrent blood analysis can be performed to
elucidate the relationship between plasma concentration
and effect, as in the current study.
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